Tag: Leider
-
Organicell Appoints Harry Leider, MD, MBA as New CEO
Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a South Florida-based clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, is pleased to announce that it has tapped Harry L. Leider, MD, MBA as its new CEO. Dr. Leider brings more than 25 years of experience as a healthcare executive and entrepreneur, with extensive experience…